LISATA THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Tax Assets, Operating Loss Carryforwards of $27.02 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $27.02M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.06M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.74M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $13.13M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $27.02M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $16.06M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $12.74M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $13.13M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $36.28M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $68.29M 10-K · filed 2022-03-22 | |
| 2019-12-31 | $70.75M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $60.54M 10-K · filed 2020-03-05 | |
| 2017-12-31 | $60.17M 10-K · filed 2019-03-14 | |
| 2016-12-31 | $79.13M 10-K · filed 2018-03-22 | $91.46M 10-K · filed 2017-03-17 |
| 2015-12-31 | $86.54M 10-K · filed 2017-03-17 | |
| 2014-12-31 | $69.05M 10-K · filed 2016-03-15 | |
| 2013-12-31 | $25.73M 10-K · filed 2016-03-15 | $43.33M 10-K · filed 2014-03-13 |
| 2012-12-31 | $25.73M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $17.82M 10-K · filed 2013-03-11 | $25.99M 10-Q · filed 2012-08-14 |
| 2010-12-31 | $17.24M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |